Role of checkpoint kinase 1 (Chk1) in the mechanisms of resistance to histone deacetylase inhibitors
about
Roles of Chk1 in cell biology and cancer therapyInhibition of histone deacetylases enhances DNA damage repair in SCNT embryos.New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells.Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyEpigenetic drugs against cancer: an evolving landscape.Stability of XIST repression in relation to genomic imprinting following global genome demethylation in a human cell line.Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells.Histone deacetylase inhibition: an important mechanism in the treatment of lymphoma.The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.Panobinostat for the treatment of multiple myeloma.Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeletonLost in translation? Ten years of development of histone deacetylase inhibitors in acute myeloid leukemia and myelodysplastic syndromes.Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma.Targeting leukemia stem cells with HDAC inhibitors and modulators of the DNA damage response.ATR/CHK1 inhibitors and cancer therapy.Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer.HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130.Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET.
P2860
Q28289548-3702A785-074E-4F54-8F4C-F99B0FE08886Q33952928-01D945B5-83FF-49BE-9E5F-B74B3B98ACE9Q34101029-8D984825-E4CD-4961-8BE8-1D05A82FF599Q34290545-15C7DEAA-FA36-4B69-9271-F74072F8B062Q34431964-F4ABA87B-A215-4675-B8AA-048A83951021Q34574262-3D4F725F-DF79-4CDF-93B9-DDE4562391E4Q36400882-39913D1C-4B8F-406A-A039-E789A3559EFEQ36814349-53593639-D93B-44E0-8168-7327ABB564E6Q36927012-7527062C-5171-4C69-83DA-BA1684009EA4Q37992104-835DF5A4-A841-4255-9C63-3DBEB93AE7EDQ38478630-0114C2F3-718E-45BD-BAC2-458C1359BDEAQ38710509-46ED23F0-5242-42B3-86EA-0DD21586D2FAQ39268578-809A9027-AFFB-42C2-B0D0-AECA006ADAD4Q40690632-A182A604-5109-4C37-B58E-4DFAECC0937DQ40819882-35C96898-39F8-4055-B7CF-A9A076C6A393Q47622968-57D6EA0E-B28E-444A-851A-28A7D1A2919DQ49544386-9A6A28E6-B2EB-4896-B39D-E26CBC98EB9DQ50317222-E617F198-B6F6-48D5-9CF3-38F89764A7F4Q53010775-6F0262E5-0C6A-4881-8E24-C06E2954B743
P2860
Role of checkpoint kinase 1 (Chk1) in the mechanisms of resistance to histone deacetylase inhibitors
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Role of checkpoint kinase 1 (C ...... histone deacetylase inhibitors
@ast
Role of checkpoint kinase 1 (C ...... histone deacetylase inhibitors
@en
type
label
Role of checkpoint kinase 1 (C ...... histone deacetylase inhibitors
@ast
Role of checkpoint kinase 1 (C ...... histone deacetylase inhibitors
@en
prefLabel
Role of checkpoint kinase 1 (C ...... histone deacetylase inhibitors
@ast
Role of checkpoint kinase 1 (C ...... histone deacetylase inhibitors
@en
P2093
P2860
P356
P1476
Role of checkpoint kinase 1 (C ...... histone deacetylase inhibitors
@en
P2093
Gisela Venta-Perez
Ju-Hee Lee
Megan L Choy
Paul A Marks
P2860
P304
19629-19634
P356
10.1073/PNAS.1117544108
P407
P577
2011-11-21T00:00:00Z